ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,014Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 71

$1.13M Total Retail Price of All Prescriptions

Rank: 11 out of 71

482 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

16% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 11,296 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 30.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 584 415 1 5
AMLODIPINE BESYLATE 442 378 2 4
OMEPRAZOLE 415 345 3 3
LEVOTHYROXINE SODIUM 332 228 4 2
LISINOPRIL 290 244 5 6
METFORMIN HCL 287 214 6 18
DONEPEZIL HCL 246 239 7 10
FUROSEMIDE 238 185 8 1
DIOVAN 236 195 9 61
HYDROCHLOROTHIAZIDE 219 153 10 19
ATORVASTATIN CALCIUM 214 196 11 20
METOPROLOL TARTRATE 197 172 12 8
FLUTICASONE PROPIONATE 194 159 13 35
GABAPENTIN 192 136 14 13
HYDROCODONE-ACETAMINOPHEN 173 89 S3 15 9
SERTRALINE HCL 167 144 16 17
CITALOPRAM HBR 165 135 17 12
NEXIUM 165 112 17 42
RANITIDINE HCL 163 134 19 36
RAMIPRIL 160 125 20 105
POTASSIUM CHLORIDE 154 110 21 11
ZOLPIDEM TARTRATE 149 102 22 26
CARVEDILOL 149 95 22 25
DIOVAN HCT 142 119 24 118
TRAMADOL HCL 140 100 25 22
NAMENDA 139 135 26 14
WARFARIN SODIUM 134 111 27 7
GLIMEPIRIDE 133 66 28 74
ALENDRONATE SODIUM 126 117 29 39
METOPROLOL SUCCINATE 122 111 30 16
ALLOPURINOL 119 99 31 41
NITROGLYCERIN PATCH 116 105 32 197
PLAVIX 109 94 33 57
TRAZODONE HCL 108 42 34 23
RISPERIDONE 106 57 35 24
LOVAZA 106 75 35 144
CLONIDINE HCL 103 67 37 48
CLOPIDOGREL 103 87 37 32
OXYCODONE-ACETAMINOPHEN 99 60 S2 39 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 68 40 86
TAMSULOSIN HCL 98 78 40 34
DIGOXIN 91 70 42 56
COMBIVENT 90 45 43 159
ATENOLOL 86 78 44 30
OXYCODONE HCL-ACETAMINOPHEN 85 24 S2 45 140
DEXILANT 85 62 45 263
METFORMIN HCL ER 84 55 47 101
ADVAIR DISKUS 83 67 48 47
JANUVIA 82 54 49 98
CYMBALTA 80 58 50 31
LOSARTAN POTASSIUM 76 63 51 21
ISOSORBIDE MONONITRATE ER 76 70 51 44
NATEGLINIDE 71 68 53 227
LEVEMIR FLEXPEN 70 48 54 207
BENAZEPRIL HCL 70 38 54 89
DILTIAZEM 24HR CD 68 66 56 72
AMLODIPINE BESYLATE-BENAZEPRIL 67 47 57 125
LEVOCETIRIZINE DIHYDROCHLORIDE 66 39 58 283
FLUOXETINE HCL 64 36 59 76
GLIPIZIDE 62 60 60 70
PRAVASTATIN SODIUM 62 43 60 28
EXFORGE 61 42 62 291
PEN NEEDLE 59 29 63 200
HYDRALAZINE HCL 59 50 63 55
NOVOLIN R 59 46 63 75
LANTUS SOLOSTAR 59 37 63 122
LIPITOR 59 48 63 111
ACTOS 58 49 68 151
SPIRONOLACTONE 57 50 69 58
FENTANYL 57 54 S2 69 68
PROAIR HFA 55 25 71 108
LYRICA 55 29 71 109
MIRTAZAPINE 54 54 73 15
AMITRIPTYLINE HCL 54 31 R 73 137
DOXAZOSIN MESYLATE 53 44 75 158
FAMOTIDINE 53 43 75 78
SYMBICORT 53 51 75 188
LANSOPRAZOLE 52 28 78 242
SPIRIVA 52 42 78 62
ISOSORBIDE DINITRATE 51 46 80 219
QUETIAPINE FUMARATE 51 27 80 38
AVODART 50 50 82 313
INSULIN SYRINGE 50 38 82 119
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.